Background and objectives This study aimed to investigate the association of vitiligo with
metabolic syndrome (MetS) and its relevant components. Material and methods We …

Generalized vitiligo (GV) is an autoimmune skin depigmenting disease characterized by loss
of functional melanocytes. Nuclear factor of activated T cells (NFATs) play a key role in …

Alterations in regulatory T (Treg) cells have been observed in generalized vitiligo (GV)
patients and decreased Forkhead Box P3 (FOXP3) has been implicated in the disease …

Vitiligo is a chronic cutaneous disease presenting with asymptomatic depigmented macular
lesions without any signs of inflammation. Since time immemorial, treatment has been …

Background Vitiligo is a chronic acquired pigmentary disorder of the skin; it results from
immunological distruction of functioning melanocytes. The cytokine TNF-α plays a central …

Background. The overall well‐being, sense of stigmatization, and treatment outcome of
persons with vitiligo are largely dependent on their social acceptance and this is linked with …

Background: Vitiligo is an acquired, idiopathic, and common depigmentation disorder. The
values of various epidemiologic parameters are often doubtful due to the methodological …

Background Apremilast is an oral phosphodiesterase-4 enzyme inhibitor that modulates the
immune system by increasing intracellular cyclic adenosine monophosphate levels and …

Background Vitiligo manifests as hypo‐to de‐pigmented macules, which are sometimes
associated with leukotrichia. For complete cosmetic improvement, the repigmentation of …

Background: Phototherapy in its different forms, is mainstay of vitiligo management.
Combining treatment modalities like topical calcipotriol (for quicker, more intense …